Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2023) Oral polio vaccine stockpile modeling: insights from recent experience. Expert Review of Vaccines 22:1, pages 813-825.
Read now
Read now
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2022) Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036. Expert Review of Vaccines 21:11, pages 1667-1674.
Read now
Read now
Kimberly M. Thompson & Kamran Badizadegan. (2022) Health economic analyses of secondary vaccine effects: a systematic review and policy insights. Expert Review of Vaccines 21:3, pages 297-312.
Read now
Read now
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2021) Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication. Expert Review of Vaccines 20:4, pages 449-460.
Read now
Read now
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2021) Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions. Expert Review of Vaccines 20:4, pages 465-481.
Read now
Read now
Articles from other publishers (32)
Kamran Badizadegan, Dominika A. Kalkowska & Kimberly M. Thompson. (2023) Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame. Medical Decision Making 43:7-8, pages 850-862.
Crossref
Crossref
Wesley Wong, Jillian Gauld & Michael Famulare. (2023) From Vaccine to Pathogen: Modeling Sabin 2 Vaccine Virus Reversion and Evolutionary Epidemiology in Matlab, Bangladesh. Virus Evolution.
Crossref
Crossref
Dominika A. Kalkowska, Eric Wiesen, Steven G. F. Wassilak, Cara C. Burns, Mark A. Pallansch, Kamran Badizadegan & Kimberly M. Thompson. (2023) Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission. Risk Analysis.
Crossref
Crossref
Dominika A. Kalkowska, Steven G. F. Wassilak, Eric Wiesen, Cara C. Burns, Mark A. Pallansch, Kamran Badizadegan & Kimberly M. Thompson. (2023) Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences. Risk Analysis.
Crossref
Crossref
Mustafa Sevindik, Celal Bal, Emre Cem Eraslan, İmran Uysal & Falah Saleh Mohammed. (2023) Medicinal mushrooms: a comprehensive study on their antiviral potential. Prospects in Pharmaceutical Sciences 21:2, pages 42-56.
Crossref
Crossref
Dominika A. Kalkowska, Kamran Badizadegan & Kimberly M. Thompson. (2023) Outbreak management strategies for cocirculation of multiple poliovirus types. Vaccine 41:25, pages 3718-3727.
Crossref
Crossref
Dominika A. Kalkowska, Kamran Badizadegan & Kimberly M. Thompson. (2022) Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan. Risk Analysis 43:4, pages 660-676.
Crossref
Crossref
Dominika A. Kalkowska, Kamran Badizadegan & Kimberly M. Thompson. (2022) Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan. Risk Analysis 43:4, pages 677-685.
Crossref
Crossref
Dominika A. Kalkowska, Steven G.F. Wassilak, Mark A. Pallansch, Cara C. Burns, Eric Wiesen, Elias Durry, Kamran Badizadegan & Kimberly M. Thompson. (2023) Outbreak response strategies with type 2-containing oral poliovirus vaccines. Vaccine 41, pages A142-A152.
Crossref
Crossref
Dominika A. Kalkowska, Arend Voorman, Mark A. Pallansch, Steven G.F. Wassilak, Stephen L. Cochi, Kamran Badizadegan & Kimberly M. Thompson. (2023) The impact of disruptions caused by the COVID-19 pandemic on global polio eradication. Vaccine 41, pages A12-A18.
Crossref
Crossref
Xinjian Wang & Guo Lin. (2023) Spreading speeds in two reaction–diffusion models for Polio disease. Communications in Nonlinear Science and Numerical Simulation 118, pages 107009.
Crossref
Crossref
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2023) Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation. Frontiers in Public Health 11.
Crossref
Crossref
Dominika A Kalkowska, Steven GF Wassilak, Eric Wiesen, Concepcion F Estivariz, Cara C Burns, Kamran Badizadegan & Kimberly M Thompson. (2023) Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation. Gates Open Research 7, pages 55.
Crossref
Crossref
Emmanuel J. Vidor & John F. Modlin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
890
913.e14
.
Lilan Xie & Yaoming Li. (2022) Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development. Vaccine 40:49, pages 7022-7031.
Crossref
Crossref
Kamran Badizadegan, Dominika A Kalkowska & Kimberly M Thompson. (2022) Polio by the Numbers—A Global Perspective. The Journal of Infectious Diseases 226:8, pages 1309-1318.
Crossref
Crossref
Heidi J. Larson, Leesa Lin & Rob Goble. (2022) Vaccines and the social amplification of risk. Risk Analysis 42:7, pages 1409-1422.
Crossref
Crossref
Natalie M. Linton, Francesca A. Lovell-Read, Emma Southall, Hyojung Lee, Andrei R. Akhmetzhanov, Robin N. Thompson & Hiroshi Nishiura. (2022) When Do Epidemics End? Scientific Insights from Mathematical Modelling Studies. Centaurus 64:1, pages 31-60.
Crossref
Crossref
Celeste Vallejo, Carl A. B. Pearson, James S. Koopman & Thomas J. Hladish. (2022) Effect of Population Partitioning on the Probability of Silent Circulation of Poliovirus. Bulletin of Mathematical Biology 84:6.
Crossref
Crossref
Nauman Ahmed, Jorge E. Macías-Díaz, Naveed Shahid, Ali Raza & Muhammad Rafiq. (2022) A dynamically consistent computational method to solve numerically a mathematical model of polio propagation with spatial diffusion. Computer Methods and Programs in Biomedicine 218, pages 106709.
Crossref
Crossref
Kimberly M Thompson. (2022) Polio eradication: what kind of world do we want?. The Lancet Infectious Diseases 22:2, pages 161-163.
Crossref
Crossref
Arooj Nasir, Dumitru Baleanu, Ali Raza, Pervez Anwar, Nauman Ahmed, Muhammad Rafiq & Tahir Nawaz Cheema. (2022) Bio-Inspired Modelling of Disease Through Delayed Strategies. Computers, Materials & Continua 73:3, pages 5717-5734.
Crossref
Crossref
Muhammad Naveed, Dumitru Baleanu, Ali Raza, Muhammad Rafiq & Atif Hassan Soori. (2022) Treatment of Polio Delayed Epidemic Model via Computer Simulations. Computers, Materials & Continua 70:2, pages 3415-3431.
Crossref
Crossref
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2022) Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative. Gates Open Research 6, pages 5.
Crossref
Crossref
Shabina Rahim, Zubair Ahmad & Jamshid Abdul-Ghafar. (2022) The polio vaccination story of Pakistan. Vaccine 40:3, pages 397-402.
Crossref
Crossref
Kimberly M. Thompson. (2021) Modeling and Managing Poliovirus Risks: We are Where we are…. Risk Analysis 41:2, pages 223-228.
Crossref
Crossref
Kimberly M. Thompson, Dominika A. Kalkowska & Kamran Badizadegan. (2020) A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States. Risk Analysis 41:2, pages 376-386.
Crossref
Crossref
Dominika A. Kalkowska & Kimberly M. Thompson. (2020) Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV. Risk Analysis 41:2, pages 312-319.
Crossref
Crossref
Megan Auzenbergs, Holly Fountain, Grace Macklin, Hil Lyons & Kathleen M O'Reilly. (2023) The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses. Gates Open Research 5, pages 94.
Crossref
Crossref
Megan Auzenbergs, Holly Fountain, Grace Macklin, Hil Lyons & Kathleen M O'Reilly. (2022) The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses. Gates Open Research 5, pages 94.
Crossref
Crossref
Megan Auzenbergs, Holly Fountain, Grace Macklin, Hil Lyons & Kathleen M O'Reilly. (2021) The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses. Gates Open Research 5, pages 94.
Crossref
Crossref
Ananda Sankar Bandyopadhyay & Grace Ruth Macklin. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
629
649
.